Semax in Australia: Nootropic & Neuroprotective Research Guide

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is derived from the ACTH(4-7) core sequence with a Pro-Gly-Pro extension for metabolic stability, developed at the Institute of Molecular Genetics, Moscow. It was approved in Russia in 1994 for use in stroke recovery, cognitive decline, and peptic ulcer treatment.

Semax does not possess the corticotropic effects of full ACTH, it does not stimulate cortisol release. Its biological activity appears to be predominantly mediated through BDNF and NGF (nerve growth factor) upregulation, and modulation of dopaminergic and serotonergic systems.

• BDNF and NGF upregulation, among the most consistent findings; Semax significantly increases BDNF and NGF expression in hippocampal and cortical tissue, supporting applications in neuroplasticity and recovery research
• Stroke and ischaemia models, extensive preclinical and clinical data from Russia documents neuroprotective effects in models of cerebral ischaemia, including reduced infarct size and improved neurological recovery scores
• Cognitive and attention research, studies have shown improvements in memory consolidation, sustained attention, and working memory under both normal and cognitively stressed conditions
• Dopamine system modulation, research suggests Semax increases dopamine receptor sensitivity and dopamine turnover in relevant brain regions, potentially contributing to its stimulatory and motivational effects
• Optic nerve pathology, a distinctive research application; clinical trials in Russia have investigated Semax in progressive myopia and glaucoma models, with some evidence of visual function preservation
• Anxiety and depression models, while primarily stimulatory, some research suggests mood-normalising effects, likely related to BDNF's role in antidepressant mechanisms

OzPeps stocks research-grade Semax with fast AU shipping. View Semax stock and pricing →

Semax is sold strictly for in-vitro laboratory research. Not TGA-approved. Not for human or animal consumption.